Category: News

The first QuiremScout cases successfully performed

The first QuiremScout® cases have been successfully performed by clinical teams in Dresden and Pisa last week. We congratulate the clinical teams, and everyone involved! QuiremScout® is the first and only CE-marked SIRT work-up product that consists of the same particle as the therapeutic microspheres. It improves the accuracy of

Read More »

QuiremScout receives CE mark

Terumo Europe today announced that QuiremScout® has received CE mark, making it available as the first and only CE marked product indicated for SIRT work up, for clinical centers throughout Europe. QuiremScout® is designed to advance the SIRT work-up procedure. It does this by improving the accuracy of predicting lung

Read More »

Radboudumc performs their first QuiremSpheres® treatment

We are pleased to announce that the Radboudumc in Nijmegen has treated its first patient with QuiremSpheres®. This milestone has been made possible by an interdisciplinary team, consisting of Dr. Marcel Janssen (Nuclear Medicine physician), Dr. Mark Arntz (Interventional Radiologist), as well  other hospital staff and technicians. The patient suffering

Read More »

Universitario Germans Trias i Pujol now uses QuiremSpheres®

On December 11th, hospital Universitario Germans Trias i Pujol located in Barcelona has successfully performed their first QuiremSpheres® treatment. This marks yet another QuiremSpheres® SIRT center on the Iberian peninsula. The patient suffering from cholangiocarcinoma was successfully treated by the team of Interventional Radiology and Nuclear Medicine led by Dr

Read More »

First QuiremSpheres® patient treatment in Lisbon, Portugal

On November 21st 2018, the first QuiremSpheres® procedure in Iberia was performed in Lisbon, Portugal. A patient, suffering from hepatocellular carcinoma, was successfully treated with QuiremSpheres® at Instituto Português de Oncologia Francisco Gentil (IPO) and Hospital Curry Cabral. This milestone was achieved through a fruitful collaboration between the Nuclear Medicine

Read More »

EANM Young Author Award

We are pleased to report that Remco Bastiaannet, PhD student at UMC Utrecht, has been awarded the EANM Young Author Award for his work on the dose-response relation in hepatic holmium-166 radioembolization. The award was presented on Monday 15 October at the EANM in Düsseldorf. We congratulate Remco and the

Read More »

NWO Industrial Doctorates funding awarded

We are very glad to announce that our joined NWO Industrial doctorates grant application together with UMC Utrecht was awarded! This will allow our colleague Martina Stella to do her PhD study in the UMC Utrecht, aimed to introduce true personalized dosimetry into everyday medical practice, resulting in an optimized

Read More »

QuiremSpheres® Observational Study

On June 7th the first site of the QuiremSpheres® Observational Study, the Universitätsklinikum Carl Gustav Carus in Dresden, Germany, was opened for registration. The observational study aims to further confirm treatment safety and efficacy using QuiremSpheres® for the treatment of patients with unresectable primary liver cancer or unresectable liver metastases.

Read More »